Q: Nice move today on what looks like a great start in getting their technology out. You say????
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Wow,, what a jump in share value,, do I hold or sell my 7500 shares?
Q: i am curious if you like profound.
they seem to have something that could be huge.
i am in my seventies and everybody around me has prostate problems.dave
they seem to have something that could be huge.
i am in my seventies and everybody around me has prostate problems.dave
Q: On August 16, 2019 Profound Medical was granted US FDA approval for TULSA-PRO. There will be more trials next year for reimbursement but PRN now has regulatory FDA approval in the US and will start commercial sales in Q4 this year. The next week or so will be very interesting.
Q: What is your current view of Profound Medical? They have received clearance from the FDA to market Tulsa-Pro. Is this not huge news? Are there further FDA approvals pending? Although up a few cents (at time of question) it is still not back to July 2018 level of $1. Would you hold?
Q: Hi 5i Team,
Pls comment on Profound Medical earning and outlook. Any positive sign ahead of this company?
Thank you for your kind assistance as always.
Pls comment on Profound Medical earning and outlook. Any positive sign ahead of this company?
Thank you for your kind assistance as always.
Q: comments,please,on recent drop in share value.
Q: Hello,
With the news this morning that Profound Medical's clinical trial proved 96% effective for the prostate cancer patients involved in the study, do you see this as a buy? Or is it still considerably risky, given that FDA approval could take some time or be denied?
Thank you.
Brad
With the news this morning that Profound Medical's clinical trial proved 96% effective for the prostate cancer patients involved in the study, do you see this as a buy? Or is it still considerably risky, given that FDA approval could take some time or be denied?
Thank you.
Brad
Q: With the new agreement with Glencore how do you feel about the future of NIF.UN? What has to happen to restart the dividend?
I would appreciate your thoughts on PRN also.
Thank you,
Bob
I would appreciate your thoughts on PRN also.
Thank you,
Bob
Q: Hi Peter and Ryan,
I am holding Profound Medical , down 35%, but I can find any reasons account for this drop lately, If I am correct they have 32m cash and almost debt free. I do not know what am I missing.
Do you see any fundamental concerns, it is now around 1% of weighting.
Should I continue to hold or sell at loss and move on?
Thank you for your help as always.
I am holding Profound Medical , down 35%, but I can find any reasons account for this drop lately, If I am correct they have 32m cash and almost debt free. I do not know what am I missing.
Do you see any fundamental concerns, it is now around 1% of weighting.
Should I continue to hold or sell at loss and move on?
Thank you for your help as always.
Q: Now things start to get really interesting.
Still risk with (i) final clinical trial data in early 2019 and FDA approval contingent on that data; and (ii) commercialization risk assuming FDA approval.
Still risk with (i) final clinical trial data in early 2019 and FDA approval contingent on that data; and (ii) commercialization risk assuming FDA approval.
Q: There was a news release today on Profound Medical Corp. Obviously it looks positive, but how significant is it for the company? What timeframe before significant growth should I expect if I start a position in this company. Thanks!
Q: In response to Dennis' question on Profound Medical, when you say you "consider it one of the more interesting small caps in the space currently." Do you mean the medical device space or small caps stocks generally?
Q: This company looks like it could be a winner. What are your views on this one. Your comments please.
Q: Who was the buyer and seller on the big block at the end of the day?
Q: Read an article on this, target price $3.50, Your analysis on this stock please. Is it worth taking a risk?
Q: Hi 5i team,
PRN was recently recommended by CIBC World Markets analyst Prakash Gowd.
What are your thoughts on this company? Is it too risky as an investment?
Thank you for your insights.
PRN was recently recommended by CIBC World Markets analyst Prakash Gowd.
What are your thoughts on this company? Is it too risky as an investment?
Thank you for your insights.
-
High Arctic Energy Services Inc. (HWO)
-
Profound Medical Corp. (PRN)
-
Grande West Transportation Group Inc. (BUS)
-
Memex Inc. (OEE)
Q: Can you give me your thoughts on the above
Thnks, Terry
Thnks, Terry
Q: Arun Menawat is now CEO. This is a very interesting development and it now makes sense why he left Novadaq. With Goodman on the Board and Arun as CEO, PRN's future appears to be in good (management) hands. Where do you see this company and its market cap in the next 1-3 years assuming they get approval to sell in Canada and then the USA. GUD has rights in Canada and I expect them to get more involved soon.
Q: what do you think about Profound Medical? I notice Jonathan Goodman is on the Board of Directors.
Best,
Linda
Best,
Linda